Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

METHYLDOPA 250 MG TABLET

Methyldopa
$7.4999per EA

Strength

250 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135032190

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

7/23/2025

Active Ingredients

METHYLDOPA

Approval Type

Authorized Generic (NDA)

FDA Application

NDA018934

On Market Since

6/29/1984

Pharmacological Classes

Adrenergic alpha2-Agonists
Central alpha-2 Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

0.0%

Generic Alternatives

1 alternative • Same active ingredient

METHYLDOPA 250 MG TABLET
Generic
62135032118•Chartwell RX LLC
$7.4999

Related Drugs

Same classification

CLONIDINE HCL 0.1 MG TABLET
Generic
00228212710•Actavis Pharma, Inc.
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
00228212750•Actavis Pharma, Inc.
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
00904744261•Major Pharmaceuticals
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
29300046801•Unichem Pharmaceuticals (USA) Inc.
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
29300046805•Unichem Pharmaceuticals (USA) Inc.
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
29300046810•Unichem Pharmaceuticals (USA) Inc.
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
43547056510•Solco Healthcare US LLC
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
43547056511•Solco Healthcare US LLC
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
50268019215•AvPAK
$0.0247
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
52817018000•TruPharma LLC
$0.0247
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy